SCHEMBL5230286

SCHEMBL5230286

CCc1sc(S(=O)(=O)Nc2ccc(Cl)cc2)cc1[N+](=O)[O-]

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 6/20 0.48
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
CES1 P23141 1/20 0.44
MAPT P10636 3/20 0.43
PKM P14618 2/20 0.43
ALDH1A1 P00352 5/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 1/20 0.41
VCAM1 P19320 1/20 0.40
TP53 P04637 1/20 0.40
KLKB1 P03952 1/20 0.40
CTSB P07858 1/20 0.40
ELANE P08246 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5228629 0.85 IDH1 (0.51) IDH1MEN1KMT2ACES1MAPT
SCHEMBL5237280 0.84 CES1 (0.49) IDH1MEN1KMT2ACES1MAPT
SCHEMBL5231329 0.79 IDH1 (0.48) IDH1MEN1KMT2ACES1MAPT
SCHEMBL5228010 0.78 ALDH1A1 (0.43) IDH1MEN1KMT2ACES1MAPT
SCHEMBL5227591 0.77 CDK1 (0.52) IDH1MEN1KMT2AMAPTPKM
SCHEMBL5228023 0.75 CA2 (0.49) MEN1KMT2AMAPTPKMALDH1A1
SCHEMBL21773233 0.75 MAPT (0.43) MEN1KMT2AMAPTPKMALDH1A1
SCHEMBL5234203 0.74 ALDH1A1 (0.42) IDH1MEN1KMT2AMAPTPKM
SCHEMBL5231082 0.74 ALDH1A1 (0.43) IDH1MEN1KMT2AMAPTPKM
SCHEMBL5227161 0.74 MEN1 (0.48) MEN1KMT2AMAPTPKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1519932-B1 BISARYLSULFONAMIDE COMPOUNDS AND THEIR USE IN CANCER THERAPY CYCLACEL LTD (GB) 2007-10-03 EP claimed